Library
LAIMĖKITE 48 098
Pravadoline (WIN 48,098) is an anti-inflammatory and analgesic drug with an IC50 of 4.9 μM and a Ki of 2511 nM at CB1, related in structure to nonsteroidal anti-inflammatory drugs (NSAIDs) such as indometacin. It was developed in the 1980s as a new antiinflammatory and prostaglandin synthesis inhibitor, acting through inhibition of the enzyme cyclooxygenase (COX).
Also known as: ((4-methoxyphenyl)-[2-methyl-1-(2-morpholin-4-ylethyl)indol-3- yl]methanone, pravadoline
Classification
- Chemical: Cannabinoid
- Chemical: Medicine
- Chemical: Synthetic cannabinoid
Effects
- Sedation
- Anxiety
- Paranoia
- Euphoria
- Dehydration
Routes of Administration
No route information available yet.
Harm Reduction
Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.
Sources
Substance data is aggregated from the following public harm-reduction and reference sources.
Links
This static page is intended as a readable non-JS and prerender-friendly library export.